For: | Kumar R, García-Compeán D, Maji T. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World J Hepatol 2022; 14(7): 1291-1306 [PMID: 36158904 DOI: 10.4254/wjh.v14.i7.1291] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i7/1291.htm |
Number | Citing Articles |
1 |
Yanru Deng, Keyu Li, Ang Li, WeiMing Hu, Wen Hu. Advances in the treatment of hepatogenous diabetes: A review. Medicine 2023; 102(46): e36068 doi: 10.1097/MD.0000000000036068
|
2 |
Silvia Espina, Diego Casas-Deza, Vanesa Bernal-Monterde, María José Domper-Arnal, Sandra García-Mateo, Alberto Lué. Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases. Nutrients 2023; 15(15): 3487 doi: 10.3390/nu15153487
|
3 |
Ye Zang, Wei Xu, Yue Qiu, Xiaomeng Jiang, Yu Fan. Presence of diabetes further heightens hepatocellular carcinoma risk in patients with hepatitis B or hepatitis C virus-related cirrhosis: A meta-analysis. Heliyon 2023; 9(8): e18425 doi: 10.1016/j.heliyon.2023.e18425
|
4 |
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash. Compensated liver cirrhosis: Natural course and disease-modifying strategies. World Journal of Methodology 2023; 13(4): 179-193 doi: 10.5662/wjm.v13.i4.179
Abstract(245) |
Core Tip(224) |
Full Article(HTML)(3020)
|
Full Article with Cover (PDF)-904K(62)
|
Full Article (Word)-330K(43)
|
Audio-691K(7)
|
Peer-Review Report-358K(37)
|
Answering Reviewers-126K(54)
|
Full Article (PDF)-694K(265)
|
Full Article (XML)-311K(41)
|
Times Cited (4)
|
Total Visits (4856)
|
Open
|
5 |
Tanmoy Maji, Mala Mahto, Sudhir Kumar, Utpal Anand, Rajeev N. Priyadarshi, Rahul Arya, Ramesh Kumar. Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications. Journal of Clinical and Experimental Hepatology 2024; 14(5): 101411 doi: 10.1016/j.jceh.2024.101411
|
6 |
Yujuan Liu, Han Hu, Chuan Li, Yin Zhang, Meichuan Li, Tao Lu, Yunchong Wu, Yanyan Yang, Ying Li, Fangwan Yang, Xiuquan Shi, Shide Lin. Impacts of the development of acute-on-chronic liver failure and bacterial infections on β-cell function and glucose homeostasis in patients with liver cirrhosis. Digestive and Liver Disease 2024; 56(4): 648 doi: 10.1016/j.dld.2023.09.009
|